Shenwan Hongyuan Group (06806) completes the issuance of 1.1 billion yuan corporate bonds.

20:42 27/02/2026

Shenwan Hongyuan (06806) announced that on February 26, 2026, Shenwan Hongyuan Securities Co., Ltd. completed the issuance of short-term corporate bonds (second tranche) to professional investors for the year 2026. The issuance size of this tranche of bonds is 1.1 billion RMB, with 500 million RMB for the first tranche with a maturity of 190 days and a coupon rate of 1.64%, and 600 million RMB for the second tranche with a maturity of 365 days and a coupon rate of 1.65%. After registration, this tranche of bonds is scheduled to be listed on the Shenzhen Stock Exchange.

Shenwan Hongyuan Group (06806) announced on February 26, 2026, that Shenwan Hongyuan Group Securities Co., Ltd. had successfully completed the public issuance of short-term corporate bonds (second tranche) for professional investors in 2026. The total issuance size of this series of bonds is RMB 1.1 billion, with RMB 500 million issued for type one bonds with a maturity of 190 days and a coupon rate of 1.64%, and RMB 600 million issued for type two bonds with a maturity of 365 days and a coupon rate of 1.65%. After registration, these bonds are expected to be listed and traded on the Shenzhen Stock Exchange.

G CHINA FIN (00431) intends to sell and Feng Limited.

US Stock Market Move | Performance outlook for 2026 falls short of expectations, Duolingo (DUOL.US) plunges over 26% in pre-market trading.

HENLIUS (02696): The phase II / III clinical study of HLX22 combined with HLX87 for first-line treatment of HER2-positive recurrent or metastatic breast cancer (BC) patients has completed the first patient dosing in China.

G CHINA FIN (00431) intends to sell and Feng Limited.

US Stock Market Move | Performance outlook for 2026 falls short of expectations, Duolingo (DUOL.US) plunges over 26% in pre-market trading.